New combination: FDA approved aclidinium bromide (Tudorza Pressair, Forest) for the long-term maintenance treatment of bronchospasm associated with COPD.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Tudorza Pressair (Aclidinium bromide)

Newsletter